The Lancet. Oncology
UK-US drug pricing deal to cost NHS £3 billion as NICE increases new medicines threshold.
Emma Wilkinson
Published: 202510.1016/S1470-2045(25)00721-1
No abstract available for this study.
Emma Wilkinson
No abstract available for this study.